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BACKGROUND: Mercury is a global pollutant, and prenatal exposure is associated with adverse health eﬀects. To date, no studies have evaluated the
association between prenatal mercury exposure and DNA hydroxymethylation, an epigenetic modiﬁcation important for tissue diﬀerentiation and em-
bryonic development.
OBJECTIVES:We sought to evaluate the association between prenatal mercury exposure and oﬀspring global DNA methylation and hydroxymethyla-
tion at birth and test for persistence of the association in childhood.
METHODS:Within Project Viva, a U.S. prebirth cohort, we examined associations of maternal second trimester red blood cell mercury (RBC-Hg) con-
centrations with global 5-hydroxymethylcytosine (%-5hmC) and 5-methylcytosine (%-5mC) DNA content in blood collected at birth (n=306), early
childhood (n=68; 2.9 to 4.9 y), and midchildhood (n=260; 6.7 to 10.5 y).
RESULTS: Median prenatal RBC-Hg concentration was 3:23 lg=g [interquartile range ðIQRÞ=3:29]. At birth, median cord blood %-5mC, %-5hmC,
and their ratio were 4.95%, 0.22%, and 24.37, respectively. The mean adjusted diﬀerence [95% conﬁdence interval (CI)] of blood %-5hmC for a dou-
bling in prenatal RBC-Hg concentration was −0:013% (−0:029, 0.002), −0:031% (−0:056, −0:006), and 0.005% (−0:007, 0.018) at birth, early, and
midchildhood, respectively. The corresponding relative adjusted change in the genomic ratio of %-5mC to %-5hmC for a doubling in prenatal RBC-
Hg concentration was 4.70% (0.04, 9.58), 22.42% (7.73, 39.11), and 0.73% (−4:18, 5.88) at birth, early, and midchildhood, respectively. No associa-
tions were present between prenatal maternal RBC-Hg and %-5mC at any time point.
CONCLUSIONS: Prenatal mercury exposure was associated with lower %-5hmC genomic content and a corresponding increase in the ratio of %-5mC
to %-5hmC in cord blood. This association was persistent in early but not midchildhood blood. Our results demonstrate the potential malleability of
epigenetic modiﬁcations associated with mercury exposure in utero. https://doi.org/10.1289/EHP1467
Introduction
Mercury is a global contaminant that bioaccumulates in the envi-
ronment. Coal-burning emissions and industrial waste are among
the major anthropogenic sources of mercury, and ocean mercury
levels have tripled since the industrial revolution (Lamborg et al.
2014). Nonoccupational human exposures predominately occur
through the consumption of ﬁsh and other seafood contaminated
with methylmercury that has been biomagniﬁed up the food chain
(Driscoll et al. 2013). Methylmercury readily crosses the placenta
and blood–brain barrier, exposing the fetus during critical win-
dows of development (Stern and Smith 2003). Prenatal exposure
to mercury, typical of regular ﬁsh consumption with elevated
mercury content, has been associated with lower cognitive test
scores and may also hinder infant growth in the ﬁrst few years of
life (Karagas et al. 2012). The speciﬁc mechanism of mercury
toxicity remains poorly characterized, but several mechanisms,
including oxidative stress, disruption of calcium homeostasis,
and alterations of neurotransmitters, among others, are hypothe-
sized to be involved (Castoldi et al. 2003). Recently, epidemio-
logical studies have shown that prenatal mercury exposure is
associated with DNA methylation at speciﬁc genomic regions
(Bakulski et al. 2015; Cardenas et al. 2015) that could serve as a
mechanism linking exposure and infant neurobehavioral out-
comes (Maccani et al. 2015).
Epigenetic modiﬁcations during fetal development play a crit-
ical role during embryogenesis regulating cell lineage commit-
ment, chromosome silencing, retrotransposon repression, and
genetic imprinting (Cheng et al. 2015). One of the most widely
studied epigenetic modiﬁcations is DNA methylation at the 5’
position of cytosine (C) nucleotides, also referred to as 5-methyl-
cytosine (5mC) (Relton et al. 2015). More recently, it has been
demonstrated that 5mC can undergo oxidation by the ten-eleven
translocation (TET) family of enzymes to form 5-hydroxymethyl-
cytosine (5hmC) (Dao et al. 2014). Regulation of gene expression
by 5hmC has been shown to be independent of 5mC and plays a
crucial role during embryogenesis, particularly in neurogenesis
(Etchegaray et al. 2015; Hahn et al. 2013). Similar to 5mC,
genomic 5hmC is cell type–speciﬁc, and it is most abundant in
neurons, embryonic stem cells, and pluripotent cells (Ruzov et al.
2011). While there is emerging literature on mercury exposure
with DNA methylation and its potential role in neurodevelopment
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and fetal programming, we are not aware of any studies that have
examined associations with 5hmC genomic content. Epigenetic
measurements associated with prenatal mercury exposure might
help elucidate mechanisms associated with toxicity, particularly
for exposures occurring in the developing fetus during critical
periods of epigenomic remodeling (Waterland and Michels
2007). Alternatively, unique epigenetic signatures could serve as
biomarkers of exposure and be used as biosensors even years af-
ter the exposure window (Ladd-Acosta 2015). Identifying if
epigenomic changes at birth and sustained throughout childhood
are associated with prenatal exposure to mercury will help eluci-
date their potential role as biomarkers of exposure or disease
susceptibility.
In the present analysis, we examined the association of prena-
tal maternal second trimester mercury exposure with global DNA
5hmC and 5mC content in cord blood. We tested for persistence
of the association among blood DNA samples collected from
children during early and midchildhood. We hypothesized that
prenatal maternal mercury concentration would be associated
with both global DNA methylation and hydroxymethylation, and
the observed association would persist into early and midchild-
hood, reﬂecting persistent epigenetic reprogramming events
occurring in utero.
Methods
Study Population
Mother–child pairs were participants in Project Viva, a prospec-
tive prebirth cohort study (Oken et al. 2014). This cohort was
recruited between 1999 and 2002 during the mothers’ ﬁrst prenatal
visits at Atrius Harvard Vanguard Medical Associates, a multispe-
cialty medical group practice in Massachusetts, United States.
Eligibility criteria included ﬂuency in English, gestational age less
than 22 wk at the ﬁrst prenatal visit, and singleton pregnancy. Of
the total 2,128 live births, cord blood was collected from 1,018
born at one of the two study hospitals. We measured global
genomic 5hmC and 5mC content in 481 cord blood samples for
mothers who provided consent for genetic analysis. Of these, 306
samples had complete covariate information and maternal prenatal
blood mercury concentrations. We evaluated persistence of cord
blood associations in 68 children with available blood epigenetic
measurements in early childhood (age: 2.9 to 4.9 y) and 260 chil-
dren with blood epigenetic measurements from midchildhood
(age: 6.7 to 10.5 y) with complete exposure and covariate informa-
tion. Not all participants were measured at all three time points: of
the 306 infants eligible for analyses in cord blood, 63 provided
early childhood blood, and 144 provided samples for midchild-
hood analyses after restricting on complete covariate information.
We did not restrict our analyses to participants with repeated epi-
genomic measurements at all three time points in order to maxi-
mize the sample size at each time point, but instead performed a
sensitivity analyses among repeated measurements (sample ﬂow
diagram is depicted in Figure S1). Mothers provided written
informed consent at recruitment and at postpartum follow-up vis-
its. The Institutional Review Board of Harvard Pilgrim Health
Care reviewed and approved all study protocols.
Maternal Prenatal Red Blood Cell Mercury
Sample collection and exposure assessment for prenatal mercury
exposure in this cohort has been previously described (Oken
et al. 2016). Brieﬂy, at the second trimester visit, we obtained a
maternal blood sample that was centrifuged to separate plasma
from blood erythrocytes. A separate aliquot of erythrocytes was
provided for mercury analysis. Aliquots were stored at −70C
and analyzed for total mercury using the Direct Mercury
Analyzer 80 (Milestone Inc.). Results are reported as mercury
concentration in the original red blood cell sample in ng/g. The
detection limit was 0:5 ng=g of sample, and the percentage recov-
ery for standards ranged from 90% to 110%. A total of 32 sam-
ples were below the limit of detection (LOD), and we used the
instrument estimated red blood cell mercury (RBC-Hg)
concentration below the LOD for analyses. During pregnancy,
participants also completed a semiquantitative food frequency
questionnaire (FFQ) that we previously calibrated against eryth-
rocyte levels of elongated n− 3 fatty acids (Fawzi et al. 2004).
Participants self-reported their consumption of ﬁsh with six fre-
quency response options ranging from “never/less than 1 per
month” to “1 or more servings per day.” We combined responses
to estimate average total ﬁsh intake as average servings per week
for the ﬁrst and the second trimesters.
DNAMethylation and Hydroxymethylation
We isolated 1 lg of DNA from buﬀy coat and enzymatically
hydrolyzed it to individual deoxyribonucleosides by a simple, one-
step DNA hydrolysis procedure consisting of a digest mix pre-
pared by adding phosphodiesterase I, alkaline phosphatase, and
benzonase Nuclease to Tris-HCl buﬀer (Sigma-Aldrich, Diegem,
Belgium). We spiked extracted DNA with an internal standard
mixture, dried it, and then hydrolyzed at 37°C for at least 8 h with
10 lL digest mixture. After hydrolysis, we added 490 lL ACN
(acetonitrile): H2O (90:8, v/v) to each sample. We prepared stock
solutions of 5mC, 5hmC, and cytosine (C) by dissolving commer-
cial standards (Sigma-Aldrich) in 22 high-performance liquid
chromatography–grade H2O to prepare the calibration standards.
Finally, we measured global genomic DNA methylation and
hydroxymethylation of cytosine nucleotides simultaneously for
each sample using ultrapressure liquid-chromatography combined
with tandem mass spectrometry, as previously described (Godderis
et al. 2015). The lower limits of detection were 0:096 ng=mL,
0:008 ng=mL, and 0:62 ng=mL for 5mC, 5hmC, and C, respec-
tively. The accuracy for the concentrations tested ranged from
87% to 114.8% of the target, and the precision expressed as
relative standard errors ranged from 0.8% to 12.1%. Global
DNA methylation is reported as a percentage of 5mC over
the sum of 5mC, 5hmC, and C [%− 5mC=5mC = ð5mC+
5hmC+CÞ], while global DNA hydroxymethylation is expressed
as a percentage of 5hmC versus the sum of 5mC, 5hmC, and
C [%–5hmC=5hmC=ð5mC+5hmC+CÞ]. A ratio of %-5mC to
%-5hmC is also reported (%-5mC=%–5hmC). All samples ana-
lyzed were above the LOD. However, a total of 24 samples, 11 in
cord blood, 4 in early, and 9 in midchildhood were below the limit
of quantiﬁcation and therefore excluded from analyses. For further
details on the methodology, see the supplementary materials on
the methods that include analytical conditions, calibration curves,
and validation parameters for our method (Tables S3–S4 and
Figure S7).
Covariates
At study enrollment, we obtained information on maternal race/
ethnicity, education, prepregnancy body mass index, smoking
during pregnancy, marital status, parity, age, and household
income. Infant sex, birth weight, and type of delivery were
abstracted from medical records. We determined birth weight for
gestational age and sex z-score from a U.S. national reference
(Oken et al. 2003). Infant race/ethnicity was collected by inter-
view. We obtained data on micronutrient intake using self-
administered semiquantitative FFQ during the ﬁrst and second
trimesters that were previously validated and modiﬁed to be used
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in pregnancy (Fawzi et al. 2004). We evaluated the eﬀect of
adjusting for intake of four methyl donors (vitamin B-12, folate,
betaine, and choline) estimated from FFQs in the ﬁrst or second
trimester of pregnancy, given that one carbon metabolism plays a
central role in DNA methylation and prenatal maternal methyl
donor intake might play a role in fetal programming of the epige-
nome (Pauwels et al. 2016).
Statistical Analyses
We estimated medians and interquartile ranges (IQRs) for
%-5hmC, %-5mC, and their ratio in cord blood across demo-
graphic and prenatal nutritional information for the study popula-
tion among all mother–child pairs available with epigenomic
measurements at birth without restricting on prenatal mercury
exposure (n=481). We tested unadjusted associations for
%-5hmC, %-5mC, and their ratio with participant characteristics
with two levels using a nonparametric Wilcoxon-rank sum test,
and use the Kruskal-Wallis test for characteristics with more than
two levels. We used Spearman correlation coeﬃcients to estimate
the association of %-5hmC and %-5mC in cord blood with levels
in blood during early or midchildhood. We also evaluated
changes in %-5mC, %-5hmC, and their ratio among subjects with
repeated measurements from cord blood and in early (n=63) or
cord blood and midchildhood (n=144) using Wilcoxon signed-
rank test for paired samples.
Both RBC-Hg concentrations and the ratio of %-5mC and
%-5hmC were right skewed. Therefore, we log2-transformed
them to approximate a normal distribution. We used separate lin-
ear regression models to estimate associations between log2-
transformed prenatal maternal RBC-Hg and %-5hmC, %-5mC,
and the log2-transformed ratio of %-5mC to %-5hmC in cord
blood as well as in blood collected during early and midchild-
hood. The ratio of %-5mC to %-5hmC was modeled separately
as a potential target for DNA demethylation.
We estimated unadjusted as well as adjusted associations
using two multivariate linear regression models: Model 1, a linear
regression model adjusted for covariates selected a priori that
were nominally associated with the outcome in univariate analy-
ses (p<0:1) or that change the eﬀect estimate for mercury by at
least 10% regardless of statistical signiﬁcance. Model 1 was
adjusted for maternal education, age at enrollment, marital status,
ﬁrst trimester vitamin B-12 intake, and second trimester ﬁsh con-
sumption, as well as child race/ethnicity, sex, gestational age, and
birth weight for gestational age z-score. The %-5mC model was
further adjusted for ﬁrst trimester folate intake, while the
%-5hmC model was adjusted by ﬁrst trimester betaine intake.
The model for the ratio of %-5mC to %-5hmC was adjusted for
both ﬁrst trimester folate and betaine intake. Model 2 was
adjusted for the same covariates as Model 1, but also included
estimated cell type proportions. Cell type composition was
estimated from genome-wide DNA methylation arrays
(HumanMethylation450 BeadChip; Illumina) available in a sub-
set of samples and estimated using the minﬁ package of R (ver-
sion 3.3.0, R Core Team) (Aryee et al. 2014). We used an adult
reference DNA methylation panel to estimate leukocyte compo-
sition in early and midchildhood and a cord blood DNA methyla-
tion reference panel, which includes nucleated red blood cells
(nRBCs), to estimate nucleated cell types at birth (Bakulski et al.
2016). Associations between cell type composition in cord blood
and both epigenomic measures are summarized in Table S1. We
report the relative percent change in the ratio of 5mC to 5hmC
per doubling in exposure, as regression coeﬃcients were esti-
mated from linear models where RBC-Hg and the ratio of
%-5mC and %-5hmC were both log2-transformed (log–log
adjusted models) to meet model assumptions. Unadjusted and
fully adjusted models were restricted to complete covariate infor-
mation used in fully adjusted models in order to compare
models.
We evaluated persistence by testing associations between
prenatal maternal RBC-Hg concentration and epigenetic meas-
urements among all participants who provided blood samples
during early or midchildhood. Estimates from unadjusted and
adjusted models are reported. Early and midchildhood adjusted
linear regression models were similar to Model 2 for cord blood
with the addition of child age in days at blood collection and
replacing cell type composition with the estimated leukocyte dis-
tribution obtained from genome-wide DNA methylation arrays
measured during early or midchildhood. We evaluated eﬀect
modiﬁcation by testing the interaction between sex and RBC-Hg
for all epigenomic measures across time points. Model ﬁt and
assumptions were examined using scatterplots of the standardized
residuals vs. the ﬁtted values, residuals vs. the leverage, and
quantile-quantile plots of the standardized residuals. All analyses
were performed using R 3.3.0 (www.r-project.org).
Results
Sociodemographic and Unadjusted Associations
A total of 481 participants with measurements of cord blood
DNA %-5mC and %-5hmC were available for bivariate analyses.
The median %-5hmC content for the entire sample was 0.22%
(IQR=0:19) (min–max: 0.024-0.87; skewness: 1.04) and the me-
dian %-5mC was 4.95% (IQR=2:52) (min–max: 2.24–10.81;
skewness: 0.94). The median ratio of %-5mC to %-5hmC in cord
blood was 24.37 (IQR=14:89). In unadjusted analyses, median
%-5hmC and %-5mC in cord blood varied by participant charac-
teristics (Table 1).
In unadjusted analyses, prenatal RBC-Hg concentration meas-
ured during the second trimester of pregnancy was associated with
global%-5hmC content measured in cord blood (Table 1). Namely,
the lowest cord blood 5hmC content was observed among partici-
pants in the highest prenatal exposure quartile (0.18%) compared to
those in the third (0.20%), second (0.25%), or ﬁrst (0.20%) quartiles
of exposure. The ratio of 5mC to 5hmC was higher in the highest
prenatal mercury exposure quartile (27.9) compared to the third
(23.9), second (23.1), or ﬁrst (23.7) quartiles of exposure.
Correlations among Epigenomic Measurements and
Longitudinal Changes
Among all participants with epigenomic measurements, global
%-5hmC and %-5mC were strongly correlated in cord blood
(rs =0:75; p<2:2× 10−16), as well as in blood collected during
early (rs =0:70; p<2:2× 10−16) and in midchildhood (rs =0:72;
p<2:2× 10−16), illustrated in Figure 1.
Among participants with repeated epigenomic measurements
(n=111), median cord blood %-5hmC was higher (0.22%) com-
pared to median %-5hmC measured in blood during early child-
hood (0.15%; p=1:7× 10−6). Similarly, median %-5mC was
higher in cord blood (5.06%) compared to the median %-5mC
measured during early childhood (4.63%; p=2:5× 10−5). Cor-
respondingly, among participants with repeated epigenomic
measurements in cord blood and midchildhood (n=225), median
cord blood %-5hmC was higher (0.24%) compared to median
levels of %-5hmC measured in blood during midchildhood
(0.16%; p=3:9× 10−10), as well as levels of %-5mC in cord
blood (5.52%) compared to measurements in midchildhood blood
(5.31%; p=3:0× 10−5).
However, median levels of %-5hmC measured during early
(0.14%) and midchildhood (0.13%) (n=61; p=0:86) and the
Environmental Health Perspectives 087022-3
Table 1. Sample characteristics of 481 mother–child pairs in the Project Viva cohort and distribution of cord blood DNA 5-hydroxymethylcytosine (5hmC)
and 5-methylcytosine (5mC) by these characteristics.
Characteristics %
%-5hmC
[median (IQR)]
%-5mC
[median (IQR)]
5mC to 5hmC ratio
[median (IQR)]
N =481 p-Value N =481 p-Value N =481 p-Value
Overall 0.22% (0.19) — 4.95% (2.52) — 24.37 (14.89) —
Maternal race/ethnicity
White 71.9 0.22 (0.19) 0.62 4.95 (2.49) 24.8 (15.4) 0.91
Black 11.9 0.23 (0.15) 4.94 (2.06) 0.09 23.5 (15.5)
Hispanic 6.9 0.24 (0.19) 6.31 (3.02) 23.5 (13.2)
Other 9.4 0.21 (0.15) 4.58 (1.99) 22.7 (10.2)
Prepregnancy BMI (kg=m2)
Underweight (<18:5) 3.5 0.19 (0.19) 0.91 5.37 (3.16) 0.63 28.5 (18.3) 0.89
Normal (18:5 –<25:0) 60.2 0.21 (0.19) 4.88 (2.64) 24.2 (14.8)
Overweight (25:0 –<30:0) 22.1 0.23 (0.20) 5.15 (2.56) 24.6 (14.4)
Obese (≥30:0) 14.2 0.23 (0.14) 4.88 (2.11) 23.1 (14.2)
Missing n=1 — — —
College graduate
No 33.5 0.24 (0.22) 0.03 5.14 (2.59) 0.03 23.3 (14.1) 0.13
Yes 66.5 0.20 (0.18) 4.82 (2.41) 24.7 (15.1)
Self-reported Smoking
Never 68.6 0.23 (0.18) 0.68 5.00 (2.49) 0.30 23.7 (15.0) 0.89
Former 20.8 0.20 (0.21) 4.70 (2.78) 25.4 (14.2)
During pregnancy 10.6 0.20 (0.17) 4.95 (1.80) 23.9 (14.7)
Nulliparous
No 53.8 0.23 (0.19) 0.71 4.82 (2.40) 0.87 24.1 (14.8) 0.72
Yes 46.2 0.21 (0.18) 5.07 (2.55) 24.5 (14.6)
Any alcohol intake (first trimester)
No 25.2 0.24 (0.19) 0.38 5.11 (2.32) 0.84 24.4 (13.0) 0.45
Yes 74.8 0.22 (0.19) 4.95 (2.54) 24.5 (15.5)
Missing n=40 — — —
Maternal age at enrollment (y)
15.7–29.6 25.2 0.23 (0.20) 0.75 5.31 (2.49) 0.56 23.8 (13.9) 0.65
>29:6–32:4 24.5 0.20 (0.19) 4.87 (2.46) 24.6 (14.5)
>32:4–35:8 25.2 0.23 (0.18) 4.71 (2.37) 23.7 (12.2)
>35:8–44:9 25.2 0.22 (0.19) 4.94 (2.68) 24.4 (17.8)
Married or cohabitating
No 9.1 0.27 (0.26) 0.03 5.84 (3.61) 0.08 22.6 (15.3) 0.24
Yes 90.9 0.22 (0.18) 4.88 (2.43) 24.5 (15.0)
Household income >$70,000
No 40 0.23 (0.22) 0.83 4.90 (2.54) 0.65 24.8 (17.1) 0.95
Yes 60 0.22 (0.17) 5.04 (2.54) 24.2 (13.5)
Missing n=36 — — —
First trimester fish (serving/wk)
0 10.9 0.25 (0.16) 0.10 5.08 (2.13) 0.71 22.4 (12.6) 0.03
>0–<3:0 75.7 0.23 (0.20) 4.97 (2.50) 24.0 (15.4)
≥3:0 13.4 0.19 (0.12) 5.98 (2.40) 28.0 (12.5)
Missing n=40 — — —
Second trimester fish (serving/wk)
0 13.2 0.24 (0.21) 0.06 5.03 (2.42) 0.94 22.6 (13.6) 0.01
>0–<3:0 75.6 0.23 (0.20) 4.95 (2.46) 24.2 (14.2)
≥3:0 11.2 0.17 (0.14) 4.88 (3.66) 30.7 (19.2)
Missing n=63 — — —
2nd trimester RBC-Hg (ng/g)
0.15–1.65 25.2 0.20 (0.18) 0.030 4.71 (2.37) 0.88 23.7 (15.3) 0.008
>1:65–3:23 24.2 0.25 (0.23) 5.27 (2.77) 23.1 (14.3)
>3:23–4:94 24.2 0.20 (0.22) 4.72 (2.84) 23.9 (14.4)
>4:94–24:5 25.2 0.18 (0.15) 5.00 (2.43) 27.8 (16.2)
Missing n=159 — — —
Child sex
Male 53.4 0.22 (0.18) 0.61 4.83 (2.46) 0.42 24.5 (15.3) 0.74
Female 46.6 0.22 (0.19) 5.05 (2.49) 23.7 (14.3)
Child race/ethnicity
White 67.8 0.22 (0.19) 0.84 4.94 (2.46) 0.03 24.6 (15.5) 0.59
Black 12.9 0.23 (0.16) 4.83 (2.06) 23.1 (14.7)
Hispanic 4.8 0.24 (0.19) 6.84 (3.91) 26.0 (18.6)
Other 14.6 0.22 (0.17) 4.71 (2.50) 24.2 (11.2)
C-section birth
No 83.4 0.22 (0.18) 0.41 4.95 (2.41) 0.49 24.1 (13.7) 0.31
Yes 16.6 0.20 (0.20) 4.72 (2.84) 26.8 (15.3)
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corresponding levels of %-5mC genomic content (4.57% and
4.42%, p=0:96) were similar. A similar trend of elevated
%-5hmC and %-5mC in cord blood compared to early or
midchildhood blood was observed among all participants
(Figure S2).
Association of 5-Hydroxymethylcytosine and
5-Methylcytosine with Prenatal Red Blood Cell Mercury
Concentrations
In unadjusted linear regression analyses, a doubling in prenatal
mercury exposure was associated with lower global %-5hmC
[b= − 0:013; 95% conﬁdence interval (CI): −0:026, 0.000;
p=0:05] and an increase in the ratio of 5mC to 5hmC
(b=5:70%; 95% CI: 1.60, 9.95; p=0:006) in cord blood. A dou-
bling in RBC-Hg concentration was associated with a 0.015%
mean decrease in global 5hmC content (95% CI: −0:029, 0.0003;
p=0:06) after adjusting for maternal education, age at enroll-
ment, marital status, ﬁrst trimester vitamin B-12, ﬁrst trimester
betaine intake, second trimester ﬁsh consumption, and child race/
ethnicity, sex, gestational age, and birth weight for gestational
age z-scores (Table 2). After further adjustment for the estimated
cell type composition, this association was slightly attenuated
(b= − 0:013; 95% CI: −0:029, 0.002; p=0:09), Table 2.
Correspondingly, a doubling in prenatal mercury exposure was
associated with a 4.80% increase in the ratio of %-5mC to
%-5hmC (95% CI: 0.18, 9.69; p=0:041) after adjusting for
potential confounders. This association remained consistent after
further adjusting for the estimated cell type composition of cord
blood (b=4:70%; 95% CI: 0.04, 9.58; p=0:047). In this sample,
no associations were observed with %-5mC in cord blood and
prenatal mercury exposure (Table 2).
In early childhood (age: 2.9 to 4.9 y), a doubling in RBC-Hg
concentration was associated with a 0.031% mean decrease in
global %-5hmC measured in blood (b= − 0:031; 95% CI:
−0:056, −0:006; p=0:016) after adjusting for covariates (Table
3). Correspondingly, in fully adjusted models, a doubling in
prenatal RBC-Hg concentration was associated with a 22.42%
increase in the ratio of %-5mC to %-5hmC in early childhood
(95% CI: 7.73, 39.11; p=2:58× 10−3). Prenatal RBC-Hg concen-
tration was not associated with%-5mC in early childhood. No asso-
ciations were observed between prenatal RBC-Hg concentration and
Table 1. (Continued.)
Characteristics %
%-5hmC
[median (IQR)]
%-5mC
[median (IQR)]
5mC to 5hmC ratio
[median (IQR)]
N =481 p-Value N =481 p-Value N =481 p-Value
Gestation length <37wks
No 95.6 0.22 (0.19) 0.69 4.93 (2.43) 0.37 24.3 (15.2) 0.93
Yes 4.4 0.23 (0.21) 6.38 (3.39) 25.1 (7.5)
BW/GA category
Small for gestational age (SGA) <10th percentile 4.4 0.18 (0.06) 0.10 4.62 (2.07) 0.53 29.5 (11.8) 0.05
Appropriate for gestational age 10–90 80.9 0.23 (0.19) 5.00 (2.56) 23.7 (13.9)
Large for gestational age (LGA) >90 14.8 0.20 (0.16) 4.85 (2.57) 26.0 (16.0)
Note: BMI, body mass index; BW, body weight; IQR, interquartile range. p-Value calculated from a Kruskal-Wallis test for groups with more than two levels and a Wilcoxon-rank
sum test for groups with only two levels.
Figure 1. *Scatter plots, Spearman correlations coeﬃcients and locally weighted scatterplot smoothing lines for 5-hydroxymethylcytosine (5hmC) and
5-methylcytosine (5mC) at three sample collection periods: at birth (cord blood, n=481), early childhood (n=117), and midchildhood blood (n=444).
Note: All participants with blood epigenomic measurements and not restricted to prenatal mercury exposure.
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global %-5hmC, %-5mC, or their ratio measured during mid-
childhood in unadjusted or fully adjusted models (Table 3). Fully
adjusted estimates of the associations of prenatal RBC-Hg con-
centration with epigenomic measures at all measured time points
are shown in Figure 2. In sensitivity analyses restricted to partici-
pants with repeated epigenomic measurements available in cord
blood and in early childhood (n=65) or cord blood and midchild-
hood (n=144) yielded consistent results (Figure S3). Analyses
stratiﬁed by gender suggested that the association might be stronger
for females. However, in fully adjusted models, there was no evi-
dence of a signiﬁcant interaction by sex for the association between
prenatal mercury exposure and global%-5hmC at birth (pinteraction =
0:42) or in early childhood (pinteraction = 0:73). Similarly, the associa-
tion between prenatal mercury exposure and the ratio of 5mC to
5hmC at birth was not signiﬁcantly diﬀerent by gender (pinteraction =
0:89) or in early childhood (pinteraction = 0:98).Adjustment formater-
nal smoking, either sustained during pregnancy or any smoking dur-
ing pregnancy, did not inﬂuence the results. Furthermore, we
observed similar resultswhensamplesbelow theLODwere replaced
by theLOD=
p
2 (results not shown).
Discussion
In this U.S. prebirth cohort, higher prenatal maternal mercury ex-
posure measured during the second trimester of pregnancy was
associated with lower global %-5hmC DNA content in cord
blood after adjusting for potential confounders. This association
was persistent in early (2.9 to 4.9 y), but not in midchildhood
(6.7 to 10.5 y). Correspondingly, prenatal mercury exposure was
associated with an increase in the ratio of %-5mC to %-5hmC in
cord blood, also persisting into early but not midchildhood. No
associations between prenatal maternal red blood cell mercury
concentrations and global %-5mC DNA content were evident.
Global 5hmC and 5mC were higher in cord blood compared to
childhood blood samples. Additionally, both 5hmC and 5mC
were positively correlated with each other in cord blood in early
and midchildhood blood. Our study highlights the potential
toxicity of prenatal mercury exposure during fetal epigenetic
reprogramming and suggests that the association might be revers-
ible during childhood.
Although 5hmC is an epigenetic modiﬁcation known to be
important during embryogenesis, little is known about its physio-
logical role and predictors. The distribution of 5hmC has been
shown to be a relatively stable epigenetic mark in vitro and in
animal models, and not just present as a transient demethylation
product, likely playing an independent regulatory function regu-
lation (Bachman et al. 2014; Iurlaro et al. 2013; Spruijt et al.
2013). For example, stem cell models have shown that enhancer
regions in the genome have greater abundance of 5hmC having a
repressive distal role on transcription (Choi et al. 2014; Yu et al.
2012). In embryonic stem cells, 5hmC plays a dual role by main-
taining chromatin structure for both upregulated genes upon dif-
ferentiation and for polycomb group repressed genes (Pastor
et al. 2011; Wu et al. 2011). Disruption of 5hmC levels by knock-
ing down TET2 function has been shown to aﬀect hematopoietic
cell diﬀerentiation, a potential contributor to myeloid malignan-
cies, highlighting the important role of 5hmC levels in blood
(Pronier et al. 2011).
Few studies have examined fetal 5hmC disruption during
human development. For example, among cases of preeclampsia
and gestational diabetes, both conditions known to aﬀect the
intrauterine environment, 5hmC content and TET2 expression in
umbilical vein tissue were observed to be altered compared to
controls, suggesting that an adverse intrauterine environment can
inﬂuence 5hmC during development (Sun et al. 2016). In this
same study, it was shown with cell cultures that hypoxia is a
potential mechanism for the observed alteration in 5hmC levels.
Furthermore, oxidative stress has been shown to alter the distri-
bution of 5hmC at several genomic regions in both cell cultures
and in vivo. For example, inducing oxidative stress led to a
global decrease in hydroxymethylation in vitro and in vivo in
the epithelium of a double-knockout animal model deﬁcient in
glutathione peroxidases 1 and 2, major antioxidant enzymes
(Delatte et al. 2015). Consistent with these models, we also
Table 2. Percent change in global 5-hydroxymethylcytosine (5hmC), global 5-methylcytosine (5mC), and their ratio in cord blood per doubling in prenatal
maternal red blood cell mercury (RBC-Hg) concentrations.
Model n
Change in global %-5hmC
(95% CI) p-Value
Change in global %-5mC
(95% CI) p-Value
%-change in the ratio of 5mC to 5hmC
(95% CI) p-Value
Unadjusted 306 −0:013% (−0:026, 0.000) 0.05 −0:029% (−0:209, 0.149) 0.74 5.70% (1.60, 9.95) 0.006
*Model 1 306 −0:015% (−0:029, 0.000) 0.06 −0:074% (−0:278, 0.128) 0.47 4.80% (0.18, 9.69) 0.04
†Model 2 306 −0:013% (−0:029, 0.002) 0.09 −0:049% (−0:251, 0.151) 0.63 4.70% (0.04, 9.58) 0.05
*Model 1 adjusted for maternal education, age at enrollment, marital status, first trimester vitamin B-12 intake, second trimester fish consumption, and child race/ethnicity, sex, gesta-
tional age, and birth weight for gestational age z-scores. Additionally, the 5-hydroxymethylcytosine (%-5hmC) model was further adjusted for first trimester betaine intake, while the
5-methylcytosine (%-5mC) model was further adjusted for first trimester folate intake. The model for the ratio of 5mC to 5hmC was adjusted for both betaine and folate intake during
the first trimester.
†Model 2: Model 1+ six estimated cell types [(CD8þ T cells, CD4þ T cells, Natural killer cells, monocytes, granulocytes, and nucleated red blood cells (nRBCs)].
Table 3. Percent change in global 5-hydroxymethylcytosine (5hmC), global 5-methylcytosine (5mC), and their ratio in blood collected early and midchildhood
per doubling in prenatal maternal red blood cell mercury (RBC-Hg) concentrations.
Childhood time point n
Change in global %-5hmC
(95% CI) p-Value
Change in global %-5mC
(95% CI) p-Value
% change in the ratio of
5mC to 5hmC
(95% CI) p-Value
Early childhood (2.9 to 4.9 y)
Unadjusted 68 −0:015% (−0:035, 0.005) 0.15 −0:022% (−0:345, 0.300) 0.89 10.69% (0.10, 22.39) 0.05
Adjusteda 68 −0:031% (−0:056, −0:006) 0.02 −0:057% (−0:451, 0.337) 0.77 22.42% (7.73, 39.11) 2:58× 10−3
Midchildhood (6.7 to 10.5 y)
Unadjusted 260 0.002% (−0:009, 0.013) 0.77 0.010% (−0:172, 0.192) 0.91 1.00% (−3:32, 5.51) 0.65
Adjusteda 260 0.005% (−0:007, 0.018) 0.41 0.094% (−0:113, 0.301) 0.37 0.73% (−4:18, 5.88) 0.78
aLinear regression models adjusted for maternal education, age at enrollment, marital status, first trimester vitamin B-12 intake, second trimester fish consumption, and child race/eth-
nicity, sex, gestational age, birth weight for gestational age z-scores, child age at blood collection, and estimated leukocyte composition in early or midchildhood (CD8þ T cells, CD4þ
T cells, Natural killer cells, monocytes, and granulocytes). Additionally, the %-5hmC model was further adjusted for first trimester betaine intake, while the %-5mC model was further
adjusted for first trimester folate intake. The model for the ratio of 5mC to 5hmC was adjusted for both betaine and folate intake during the first trimester.
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observed a decrease in global measurements of 5hmC in the
cord blood associated with increasing levels of prenatal mer-
cury exposure. Interestingly, the leading hypothesized mecha-
nisms for mercury-associated toxicity include the generation of
reactive oxygen species and increased oxidative stress (Farina
et al. 2011a; Farina et al. 2011b). Moreover, metal-induced oxi-
dative stress is also thought to be a unifying process for epige-
netic disruption (Baccarelli and Bollati 2009; Hou et al. 2012).
Oxidative stress or antioxidant depletion might be involved in
the observed association between prenatal mercury exposure and
lower 5hmC content. Future experimental studies could test this
hypothesis.
A few studies have shown that 5hmC in blood might be sensi-
tive to environmental exposures. In a cross-sectional study, in
adult participants from the Strong Heart Study (American Indians
from Arizona, Oklahoma, North Dakota, and South Dakota; 45 to
74 y old), higher cadmium and arsenic exposure were each asso-
ciated with higher %-5hmC of blood DNA (Tellez-Plaza et al.
2014). This study also reported moderate correlations (rs: 0.32 to
0.54) for the relationship between 5hmC and 5mC. Likewise,
another study of adults reported similar Pearson correlations
between 5hmC and 5mC measured in blood at diﬀerent time
points (r=0:35 to 0.22) and an increase in %-5hmC with ele-
vated particulate matter ≤10lm (PM10) exposure (Sanchez-
Guerra et al. 2015). Although these two studies reported lower
correlations among epigenomic measures (5hmC and 5mC) com-
pared to our data, their target populations were adults, and both
studies used an enzyme-linked immunosorbent assay commercial
method for the quantiﬁcation of 5mC and 5hmC that diﬀers from
our mass spectrometry methodology. In these two previous stud-
ies, arsenic and PM10 exposure were positively associated with
%-5hmC content, but not %-5mC. We observed an inverse asso-
ciation between prenatal mercury exposure and %-5hmC, but the
association with %-5mC was null, suggesting that 5hmC might
be a more sensitive biomarker of environmental exposures.
Moreover, the observed increase in the ratio of 5mC to 5hmC
paired with the null associations for 5mC suggests that prenatal
mercury exposure does not inﬂuence the demethylation pathway
of 5mC to the 5hmC product. Instead, our results suggest that the
5hmC association with prenatal maternal mercury exposure is in-
dependent of 5mC levels in the genome. The health implications
of the associations between metals and %-5hmC in both children
and adults are currently unknown. Prospective epidemiological
and molecular studies with metal exposure assessment, epigenetic
measures that distinguish 5hmC from 5mC, and health end points
over the follow-up are needed.
Several studies have examined the association between prena-
tal mercury exposure and DNA methylation across the genome.
Namely, a previous epigenome-wide association study of
mother–infant pairs documented hypermethylation of top CpG
sites along with shifts in cell type composition of cord blood rela-
tive to maternal methylmercury concentrations in a population
exposed to low levels of mercury mainly through the diet
(Cardenas et al. 2015). Another study of mother–infant pairs
likely exposed through dietary sources documented methylation
changes of a genomic region associated with both total prenatal
mercury and methylmercury exposure, but the association was
attenuated after adjusting for cell type composition (Bakulski
et al. 2015). In a study of dental health professionals occupation-
ally exposed to mercury, a cross-sectional relationship was
observed between methylmercury concentration and hypo-
methylation of a candidate gene (SEPP1), but no relationship
with global DNA methylation of repetitive elements such as
Long Interspersed Element (LINE-1) (Goodrich et al. 2013). In
an epigenome-wide association study of our cohort, we observed
that prenatal maternal RBC-Hg concentration was associated
with regional DNA methylation of the PON1 gene in cord blood
for males, an association that persisted in early childhood but was
attenuated in midchildhood, supporting our ﬁndings of the poten-
tial malleability of the epigenetic modiﬁcations early in life
(Cardenas et al. 2017). None of the gene-speciﬁc CpGs previ-
ously reported to be associated with prenatal mercury exposure in
our cohort were signiﬁcantly correlated with global measures of
DNA methylation or DNA hydroxymethylation (Figure S4).
Although PON1 cord blood DNA methylation was associated
with child cognitive function in early childhood in our previous
Epigenome Wide Association Study (EWAS) (Cardenas et al.
2017), we did not observe an association for global %-5mC and
Figure 2. Fully adjusted association for A) 5-hydroxymethylcytosine (%-5hmC); B) 5-methylcytosine (%-5mC;) and C) %-diﬀerence in the ratio of 5mC to
5hmC per doubling in prenatal maternal mercury concentrations.
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%-5hmC measured in cord blood or early childhood with child
cognitive function (Table S2). Additionally, we tested whether
DNA methylation measurements from the Illumina Inﬁnium
HumanMethylation450 BeadChip or 450K array were associated
with our global measurements of %-5hmC and %-5mC among
the same samples using the Global Analysis of Methylation
Proﬁles package of R (Zhao et al. 2015). Our global measures of
DNA %-5hmC were not associated with the cumulative density
function (p=0:18) or the density distribution of the 450K meas-
urements (p=0:10). Furthermore, our global measurements of
DNA %-5mC was not signiﬁcantly associated with either the cu-
mulative density function (p=0:11) or the density distribution of
the 450K measurements (p=0:14). As sensitivity analyses, we
also examined if any individual CpG site from the 450K array
was associated with global %-5hmC and evaluated whether those
CpGs were also associated with prenatal mercury exposure. After
adjusting for covariates and multiple comparisons, we did not
observe any signiﬁcant associations between CpGs correlated
with global %-5hmC and prenatal mercury exposure (Figure S5).
However, these results must be interpreted with caution, as the
genomic inﬂation for the EWAS of %-5hmC was relatively large
(k=2:2), which that could lead to the overestimation of statistical
signiﬁcance (van Iterson et al. 2017). Additionally, a more appro-
priate study design is needed to address this question, for exam-
ple, implementing oxidative bisulﬁte treatment of samples to
distinguish individuals CpGs that are hydroxymethylated.
Processing and technical batch adjustment for the 450K data
have been previously described (Cardenas et al. 2017).
Although these studies measured localized rather than global
genomic DNA methylation, they provide evidence that prenatal
exposure could potentially aﬀect DNA methylation levels of spe-
ciﬁc genomic regions. Furthermore, in two animal studies con-
ducted in brain tissue of polar bears (Pilsner et al. 2010) and
whole blood from alligators (Nilsen et al. 2016), mercury levels
were negatively associated with global DNA methylation of each
speciﬁc tissue, suggesting that mercury might lead to demethyla-
tion of the genome independent of tissue type. In sensitivity anal-
yses, we investigated whether cord blood global %-5hmC or
%-5mC were associated with other measures of DNA methyla-
tion, such as LINE-1 DNA methylation previously measured in
this cohort (Boeke et al. 2012). We did not see any signiﬁcant or
strong correlations between our global epigenetic measures and
LINE-1 DNA methylation. Furthermore, prenatal mercury expo-
sure was not associated with LINE-1 cord blood DNA methyla-
tion (Figure S6).
The adjusted associations of prenatal mercury exposure with
%-5hmC, along with the corresponding increase in the ratio of
%-5mC to %-5hmC, were persistent into early childhood but
absent in midchildhood, even though our sample size was greater
in the latter. This relationship suggests that the 5hmC association
with prenatal mercury exposure might be malleable and poten-
tially reversible throughout childhood. This is also supported by
our sensitivity analyses, showing that among individuals with
repeated epigenomic measurements in cord blood and early child-
hood (n=63), the association persists, but among individuals
with repeated epigenomic measurements in cord blood and mid-
childhood (n=144), the association does not persist. Global
measurements of both 5hmC and 5mC have been shown to
decline with age, consistent with our observation of higher levels
for both epigenomic measures in cord blood compared to early or
midchildhood blood (Buscarlet et al. 2015). However, both epi-
genomic measurements were not signiﬁcantly diﬀerent in early
and midchildhood.
Measuring global 5hmC and 5mC content in the genome is
innovative in epidemiological studies. Liquid chromatography
combined with tandem mass spectrometry has been shown to be
among the top two best-performing assays for global DNA epige-
nomic measurements in a multicenter benchmarking study and
observed to most accurately reﬂect expected diﬀerences in global
DNA methylation (BLUEPRINT Consortium et al. 2016). Also,
our global epigenomic measurements in cord blood might diﬀer
fromprevious studies, as both theproportionof 5hmCand5mCrep-
resent the estimated amount of modiﬁed cytosine in the entire ge-
nome as opposed to other global assays that only target repetitive
DNA elements and are a proxy for global epigenomic modiﬁca-
tions. For example, we did not see any signiﬁcant associations
between our global measurement of 5hmC and 5mC with either
LINE-1 cord blood DNA methylation or the global distribution of
CpG methylation measured with the 450K array. This is not unex-
pected, as both LINE-1 and the 450K array provide methylation
measurements at very distinct genomic positions and have limited
coverage of all CpGs present in the human genome. In contrast, our
liquid chromatographymethodhas a trueglobal genomic coverage.
However, an important limitation of this method is the lack of
information on localized methylation or hydroxymethylation.
Given the previously characterized dual role of 5hmC in stem
cells, it would be beneﬁcial to measure 5hmC with greater resolu-
tion in order to characterize its role in transcriptional regulation
and response to environmental exposures at speciﬁc genomic
coordinates within DNA samples. Another important limitation
of this study is that both epigenomic measurements were taken
from cord blood and blood DNA, and not isolated from a target
organ, such as the brain. Given the cell type speciﬁcity of 5hmC
and 5mC, our measurement represents an aggregate of diﬀerent
nucleated blood cell types. However, we did adjust for major cell
type distributions, including nRBCs found in cord blood, esti-
mated from DNA methylation arrays shown to have good corre-
lations with laboratory measurements (Cardenas et al. 2016). Our
cell type adjustment minimizes the chance that our ﬁndings are
due to cell type heterogeneity. Our study has several strengths,
including the relatively large number of samples, the prospective
assessment of both epigenomic measurements at birth and at two
time points during childhood, and the use of an objective bio-
marker of prenatal mercury exposure at a sensitive window of fe-
tal development during pregnancy. We used second trimester
maternal RBC-Hg concentrations as an unbiased biomarker of
exposure with an estimated half-life of 72 d (Mahaﬀey et al.
2004), and 70-95% of the red blood cell mercury content is esti-
mated to be methylmercury (Mortensen et al. 2014). In our
cohort, we also expect that the major source of exposure is die-
tary, mainly from ﬁsh, although we cannot rule out other sources.
Although this is an observational study and confounding cannot
be ruled out, we adjusted for many diﬀerent confounders, includ-
ing important prenatal maternal nutritional information, that have
been characterized and validated in our cohort.
Conclusion
Our study is the ﬁrst to show that prenatal mercury exposure, a
global persistent environmental contaminant, is associated with
lower 5hmC levels in cord blood DNA, and this association per-
sists in early childhood blood, but likely not beyond that time pe-
riod. Levels of 5hmC play a critical role in embryogenesis and cell
lineage commitment, and are now appreciated as an independent
epigenetic control mechanism of transcriptional regulation. The
prenatal toxicity of mercury might be mediated by the observed
alteration in 5hmCcontent serving as biomarker of exposure or dis-
ease susceptibility. Furthermore, our results highlight the potential
role of prenatal mercury exposure during fetal epigenetic program-
ming and suggest that this association is reversible in childhood.
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